ABL Bio (Korea) Performance
| 298380 Stock | KRW 26,600 1,250 4.49% |
The firm shows a Beta (market volatility) of 0.26, which signifies not very significant fluctuations relative to the market. As returns on the market increase, ABL Bio's returns are expected to increase less than the market. However, during the bear market, the loss of holding ABL Bio is expected to be smaller as well. At this point, ABL Bio has a negative expected return of -0.23%. Please make sure to confirm ABL Bio's jensen alpha, treynor ratio, and the relationship between the standard deviation and total risk alpha , to decide if ABL Bio performance from the past will be repeated in the future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days ABL Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Total Cashflows From Investing Activities | 20.2 B |
ABL |
ABL Bio Relative Risk vs. Return Landscape
If you would invest 3,240,000 in ABL Bio on August 28, 2024 and sell it today you would lose (580,000) from holding ABL Bio or give up 17.9% of portfolio value over 90 days. ABL Bio is generating negative expected returns and assumes 4.6447% volatility on return distribution over the 90 days horizon. Simply put, 41% of stocks are less volatile than ABL, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
ABL Bio Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ABL Bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ABL Bio, and traders can use it to determine the average amount a ABL Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0493
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 298380 |
Estimated Market Risk
| 4.64 actual daily | 41 59% of assets are more volatile |
Expected Return
| -0.23 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average ABL Bio is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ABL Bio by adding ABL Bio to a well-diversified portfolio.
ABL Bio Fundamentals Growth
ABL Stock prices reflect investors' perceptions of the future prospects and financial health of ABL Bio, and ABL Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ABL Stock performance.
| Return On Equity | 5.6 | |||
| Return On Asset | -0.31 | |||
| Operating Margin | (6.16) % | |||
| Current Valuation | 866.33 B | |||
| Shares Outstanding | 45.3 M | |||
| Price To Sales | 101.38 X | |||
| Revenue | 5.33 B | |||
| EBITDA | (53.58 B) | |||
| Cash And Equivalents | 21.59 B | |||
| Total Debt | 72.32 M | |||
| Debt To Equity | 1.40 % | |||
| Cash Flow From Operations | (40.61 B) | |||
| Total Asset | 65.45 B | |||
About ABL Bio Performance
By analyzing ABL Bio's fundamental ratios, stakeholders can gain valuable insights into ABL Bio's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ABL Bio has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ABL Bio has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. ABL Bio is traded on Korean Securities Dealers Automated Quotations in South Korea.Things to note about ABL Bio performance evaluation
Checking the ongoing alerts about ABL Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ABL Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| ABL Bio generated a negative expected return over the last 90 days | |
| ABL Bio has high historical volatility and very poor performance | |
| The company reported the revenue of 5.33 B. Net Loss for the year was (43.56 B) with profit before overhead, payroll, taxes, and interest of 8.06 B. | |
| ABL Bio has accumulated about 21.59 B in cash with (40.61 B) of positive cash flow from operations. | |
| Roughly 32.0% of the company shares are owned by insiders or employees |
- Analyzing ABL Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ABL Bio's stock is overvalued or undervalued compared to its peers.
- Examining ABL Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ABL Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ABL Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ABL Bio's stock. These opinions can provide insight into ABL Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for ABL Stock analysis
When running ABL Bio's price analysis, check to measure ABL Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABL Bio is operating at the current time. Most of ABL Bio's value examination focuses on studying past and present price action to predict the probability of ABL Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABL Bio's price. Additionally, you may evaluate how the addition of ABL Bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |